American Academy of Pediatrics. (2022). Clinical Practice Guideline: Management of Hyperbilirubinemia in the Newborn Infant 35 or More Weeks of Gestation. Pediatrics, 150(3), e2022058859.
[2]
Brouwer, B., & van der Boom, J. (2021). Neonatal Jaundice: A Review of Current Guidelines and Treatment Protocols. Journal of Perinatal Medicine, 49(6), 678-689.
[3]
Dijk, P. H., & Hulzebos, C. V. (2020). Phototherapy for Neonatal Hyperbilirubinemia. Neoreviews, 21(8), e512-e520.
Kaplan, M., & Hammerman, C. (2021). Glucose-6-Phosphate Dehydrogenase Deficiency and Neonatal Hyperbilirubinemia. Seminars in Fetal and Neonatal Medicine, 26(2), 101-108.
[6]
Kliegman, R. M., Stanton, B. F., St. Geme, J. W., & Schor, N. F. (2020). Nelson Textbook of Pediatrics (21st ed.). Philadelphia: Elsevier.
[7]
Maisels, M. J., & Bhutani, V. K. (2019). Neonatal Hyperbilirubinemia. In R. J. Martin, A. A. Fanaroff, & M. C. Walsh (Eds.), Fanaroff and Martin's Neonatal-Perinatal Medicine (11th ed.). Philadelphia: Elsevier.
[8]
Olusanya, B. O., Kaplan, M., & Hansen, T. W. (2020). Neonatal Hyperbilirubinemia: A Global Perspective. The Lancet Child & Adolescent Health, 4(12), 921-930.
[9]
World Health Organization. (2021). Guidelines on Neonatal Jaundice Management. Geneva: WHO.
[10]
Watchko, J. F., & Tiribelli, C. (2021). Bilirubin-Induced Neurologic Damage—New Challenges for an Old Molecule. Pediatric Research, 89(3), 512-518.